Prof. Dr. Peter Goebell



Organisationseinheit


Urologische Klinik
Medizinische Fakultät


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 7 Go to next page Go to last page

Black, P.C., Goebell, P., Kamat, A.M., Nawroth, R., Seiler, R., Williams, S.B., & Schmitz-Dräger, B.J. (2019). Editorial: Basic research in bladder cancer – refining the tools. 3rd IBCN seminars series1. Urologic Oncology-Seminars and Original Investigations. https://dx.doi.org/10.1016/j.urolonc.2019.01.003
Goebell, P., Hermann, E., Kube, U., Doehn, C., Marschner, N., Dietel, A.,... Bergmann, L. (2019). Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study. Oncology Research and Treatment, 42(1-2), 57-66. https://dx.doi.org/10.1159/000494278
Grünwald, V., Doehn, C., & Goebell, P. (2019). Molecular tumor board—renal cell carcinoma Molekulares Tumorboard – Nierenzellkarzinom. Urologe. https://dx.doi.org/10.1007/s00120-019-0965-7
Boormans, J.L., Zwarthoff, E.C., Black, P.C., Goebell, P., Kamat, A.M., Nawroth, R.,... Schmitz-Dräger, B.J. (2019). New horizons in bladder cancer research. Urologic Oncology-Seminars and Original Investigations. https://dx.doi.org/10.1016/j.urolonc.2018.12.014
Kahlmeyer, A., Goebell, P., & Wullich, B. (2019). Presurgical assessments (Assessments vor Operationen). Urologe, 58(4), 373-380. https://dx.doi.org/10.1007/s00120-019-0888-3
Kahlmeyer, A., Goebell, P., & Wullich, B. (2019). Presurgical assessments. Urologe, 58(4), 373-380. https://dx.doi.org/10.1007/s00120-019-0888-3
Williams, S.B., Hudgins, H.K., Ray-Zack, M.D., Chamie, K., Smaldone, M.C., Boorjian, S.A.,... Gore, J.L. (2019). Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer. European Urology Oncology, 2(2), 119-125. https://dx.doi.org/10.1016/j.euo.2018.07.006
Wülfing, C., Bögemann, M., Goebell, P., Hammerer, P., Machtens, S., Pfister, D.,... Schostak, M. (2019). Treatment situation in metastastic Castration Naive Prostate Cancer (mCRPC) and the implications on clinical routine Therapiesituation beim metastasierten kastrationsnaiven Prostatakarzinom (mCNPC) und die Auswirkungen im klinischen Alltag. Urologe. https://dx.doi.org/10.1007/s00120-019-0925-2
Schmidkonz, C., Cordes, M., Schmidt, D., Bäuerle, T., Goetz, T.I., Beck, M.,... Ritt, P. (2018). 68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. https://dx.doi.org/10.1007/s00259-018-4042-z
Schmidkonz, C., Hollweg, C., Beck, M., Reinfelder, J., Götz, T., Sanders, J.,... Ritt, P. (2018). 99m Tc-MIP-1404-SPECT/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer. Prostate, 78(1), 54-63. https://dx.doi.org/10.1002/pros.23444

Zuletzt aktualisiert 2019-26-03 um 22:51